June 23 Quick Takes: Illumina selects first biotechs for U.K. accelerator; plus updates from the NASDAQ IPO queue, and venture rounds for Surrozen, Tara

Illumina launches U.K. accelerator campus
Illumina Inc. (NASDAQ:ILMN) selected three companies to join the first cohort of its new Cambridge, U.K.-based accelerator, and four genomics start-ups for the eleventh funding cycle at its San Francisco Bay Area campus. The

Read the full 384 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE